期刊
JOURNAL OF BIOPHOTONICS
卷 13, 期 10, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/jbio.202000203
关键词
biomedical photonics; diabetes mellitus; imaging; optical noninvasive diagnostics; spectroscopy
资金
- Academy of Finland [318281, 325097, 326204]
- H2020 Marie Sklodowska-Curie Actions [839888]
- National Research Tomsk State University Academic D.I. Mendeleev Fund Program
- Marie Curie Actions (MSCA) [839888] Funding Source: Marie Curie Actions (MSCA)
- Academy of Finland (AKA) [325097, 326204, 318281, 325097, 318281, 326204] Funding Source: Academy of Finland (AKA)
The prevalence of diabetes complications is a significant public health problem with a considerable economic cost. Thus, the timely diagnosis of complications and prevention of their development will contribute to increasing the length and quality of patient life, and reducing the economic costs of their treatment. This article aims to review the current state-of-the-art biophotonics technologies used to identify the complications of diabetes mellitus and assess the quality of their treatment. Additionally, these technologies assess the structural and functional properties of biological tissues, and they include capillaroscopy, laser Doppler flowmetry and hyperspectral imaging, laser speckle contrast imaging, diffuse reflectance spectroscopy and imaging, fluorescence spectroscopy and imaging, optical coherence tomography, optoacoustic imaging and confocal microscopy. Recent advances in the field of optical noninvasive diagnosis suggest a wider introduction of biophotonics technologies into clinical practice and, in particular, in diabetes care units.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据